Literature DB >> 10772374

Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.

S L Ellis1, S J Billups, D C Malone, B L Carter, D Covey, B Mason, S Jue, J Carmichael, K Guthrie, C D Sintek, R Dombrowski, D R Geraets, M Amato.   

Abstract

The purpose of this study was to describe and evaluate the activities and interventions provided by ambulatory care clinical pharmacists during the IMPROVE (Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers) study. A total of 523 patients were randomized into the intervention arm at nine Veterans Affairs medical centers if they were considered to be at high risk for drug-related problems. Patients randomized to the control group had no interventions and they are not reported. Using a standard form, pharmacists were asked to document the length of visit, method of contact, medical conditions addressed, and drug-related problems addressed and resolved during each contact. Seventy-eight ambulatory care clinical pharmacists documented 1855 contacts over 12 months, an average of 3.54 +/- 2.31/patient. The length of visits was 15 minutes or more for 73% of contacts. In-person contacts accounted for 1421 visits (76.6%), with the remainder being telephone contacts. During each contact the average number of drug-related problems addressed and resolved were 1.64 +/- 1.16 and 1.14 +/- 0.98, respectively. More drug-related problems were addressed and resolved when visits were 15 minutes or longer (p=0.001) and when the contact was in person (p=0.001). These data may provide information to clinical pharmacists developing pharmacy-managed clinics for patients at high risk for drug-related problems. The information may be a benchmark for types of interventions that can be made, as well as the time commitments required to make them.

Entities:  

Mesh:

Year:  2000        PMID: 10772374     DOI: 10.1592/phco.20.5.429.35055

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  11 in total

1.  The Iowa Continuity of Care study: Background and methods.

Authors:  Barry L Carter; Karen B Farris; Paul W Abramowitz; David B Weetman; Peter J Kaboli; Jeffrey D Dawson; Paul A James; Alan J Christensen; John M Brooks
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

Review 2.  Application of drug-related problem (DRP) classification systems: a review of the literature.

Authors:  Benjamin J Basger; Rebekah J Moles; Timothy F Chen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-02       Impact factor: 2.953

Review 3.  Comparison of drug-related problem risk assessment tools for older adults: a systematic review.

Authors:  Emmi Puumalainen; Marja Airaksinen; Sanni E Jalava; Timothy F Chen; Maarit Dimitrow
Journal:  Eur J Clin Pharmacol       Date:  2019-12-10       Impact factor: 2.953

4.  A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.

Authors:  John Sellors; Janusz Kaczorowski; Connie Sellors; Lisa Dolovich; Christel Woodward; Andrew Willan; Ron Goeree; Roxanne Cosby; Kristina Trim; Rolf Sebaldt; Michelle Howard; Linda Hardcastle; Jeff Poston
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

5.  Assessing the impact of multi-compartment compliance aids on clinical outcomes in the elderly: a pilot study.

Authors:  Carolina Mosca; Margarida M Castel-Branco; Ana C Ribeiro-Rama; Margarida M Caramona; Fernando Fernandez-Llimos; Isabel V Figueiredo
Journal:  Int J Clin Pharm       Date:  2013-12-01

Review 6.  Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis.

Authors:  Richard Holland; James Desborough; Larry Goodyer; Sandra Hall; David Wright; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

Review 7.  A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Authors:  Peter A G M De Smet; Wilma Denneboom; Cees Kramers; Richard Grol
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Do patients' expectations influence their use of medications? Qualitative study.

Authors:  Lisa Dolovich; Kalpana Nair; Connie Sellors; Lynne Lohfeld; Annie Lee; Mitchell Levine
Journal:  Can Fam Physician       Date:  2008-03       Impact factor: 3.275

Review 9.  Repeat prescribing: scale, problems and quality management in ambulatory care patients.

Authors:  Peter A G M De Smet; Maaike Dautzenberg
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes.

Authors:  Bob W van Roozendaal; Ines Krass
Journal:  Pharm World Sci       Date:  2009-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.